Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Arcus Biosciences, Inc. Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer August 08, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update August 03, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants July 26, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study May 09, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants April 11, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants March 24, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants February 24, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update February 23, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants January 11, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones January 10, 2022 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration December 21, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers GILD RCUS Arcus Biosciences Announces New Employment Inducement Grants December 09, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia November 30, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference November 22, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants November 09, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab November 08, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights November 02, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants September 09, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants August 24, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants August 10, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights August 05, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants July 26, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants May 25, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Announces New Employment Inducement Grants April 26, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting April 10, 2021 From Arcus Biosciences, Inc. Via Business Wire Tickers RCUS Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.